Cargando…
Subcutaneous immunoglobulin therapy for adult patients with primary immunodeficiency disease: Qatar experience
Introduction: Subcutaneous immunoglobulin (SCIG) and intravenous immunoglobulin (IVIG) are used for the treatment of primary immunodeficiency (PIDD). SCIG is as effective as IVIG in preventing infections.(1) However, SCIG has advantages over IVIG as it causes fewer systemic reactions and can be infu...
Autores principales: | Thalappil, Sherin, Khalil, Sally, Hassini, Slim, Al-Nesf, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
HBKU Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660831/ https://www.ncbi.nlm.nih.gov/pubmed/38025333 http://dx.doi.org/10.5339/qmj.2023.sqac.3 |
Ejemplares similares
-
Aeroallergens sensitization pattern in atopic patients in Qatar: A retrospective study
por: Thalappil, Sherin, et al.
Publicado: (2023) -
A review of patch-test data over the period of eight years in the allergy and immunology department in Qatar
por: Khalil, Sally, et al.
Publicado: (2023) -
The Second Qatar Allergy and Immunology Conference: An Editorial
por: Ali AL-Nesf, Maryam, et al.
Publicado: (2023) -
The rate of exacerbations in patients with asthma in Qatar: A retrospective study during 2019-2021
por: Isaifan, Dina, et al.
Publicado: (2023) -
Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)
por: Purayil, Saleema, et al.
Publicado: (2022)